In Depth 28 May 2025 Myasthenia gravis treatments: what’s on the horizon? …are AChR- positive compared to a 4.7-point recovery in the lower dose arm. Although batoclimab was Immunovant’s long-standing candidate until last year, it switched focus to gear its anti-FcRn antibody… May 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2023 Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered …include its lead asset CBS004, a monoclonal antibody for the treatment of autoimmune conditions. As part of the agreement, CBS004 will be renamed to ANB101 next year. The candidate is… December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Nov 2025 Eight CAR-T cell therapy companies you should know about …power the clinical development of its CAR-T candidate WU-CART-007. The allogeneic candidate is in phase 2 trials to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (LBL). T-ALL is an aggressive blood cancer that stems from… November 19, 2025 - 16 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway …B funding round to push its preclinical candidates to the clinic. And making a name for itself in the metabolic disease therapeutics space, Confo has discovered antibody-based GPCR agonists that… October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2025 Top biotech deals of December 2024 …and development (R&D) plans. Biotech deals by approach in December 2024 Biotechs continue antibody-drug conjugates R&D streak As usual, licensing deals for antibody-drug conjugates make the cut. American pharma Gilead… January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2025 Top biotech deals of January 2025 …of drugs to treat cancer. Chinese biotech Innovent and Swiss multinational company Roche to advance the development of IBI3009, a DLL3-targeted ADC candidate. The candidate has already secured Investigational New… February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Mar 2023 Antiverse identifies therapeutic antibodies targeting GPCRs …conjugated with antibody candidates. Data in blue represents specific binders, data in orange shows candidates which bound untransfected cells (non-specific binders), and data in grey shows non-binding controls. GPCRs GPCRs… March 2, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Mar 2025 Nine biotechs thriving in Seattle in 2025 …engineered to improve expression and EGFR antibody sensitivity. Preclinically, the candidate overcame obstacles typically linked with T cell therapies like poor expansion, according to Aaron Foster, chief scientific officer (CSO)… March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 May 2024 8 Swedish companies spearheading the country’s biotech scene …precisely identifying antibodies that bind to the specific target protein easier, the Lund-headquartered company’s antibody library n-CoDeR contains more than 30 billion human antibody genes stored within phages in test… May 28, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jul 2025 Seven biotechs in Belgium making leaps in the clinic …disease therapies Lead candidate: AGMB-129 (ALK5 inhibitor for Crohn’s disease) Based in the port city of Ghent in Belgium, AgomAb develops antibody treatments for fibrosis using technology licensed from the… July 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Aug 2025 Six psychedelic drug companies aiming to revolutionize mental health treatment …treatments. Table of contents Atai Life Sciences Headquarters: Germany Lead candidate: BPL-003 Recent news: Raised $50 million in a private placement Atai Life Sciences was set up in 2018 in… August 12, 2025 - 2 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 10 May 2024 How to prepare for an interview at a biotech company …and potential for growth to excel in the field. When we asked Aiken what she believes biotech companies generally look for in successful candidates, she replied: “At Arcellx, successful candidates… May 10, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email